These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28663594)

  • 1. Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus.
    Tam ZY; Ng SP; Tan LQ; Lin CH; Rothenbacher D; Klenk J; Boehm BO; ;
    Sci Rep; 2017 Jun; 7(1):4392. PubMed ID: 28663594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-targeted urine metabolomics and associations with prevalent and incident type 2 diabetes.
    Salihovic S; Broeckling CD; Ganna A; Prenni JE; Sundström J; Berne C; Lind L; Ingelsson E; Fall T; Ärnlöv J; Nowak C
    Sci Rep; 2020 Oct; 10(1):16474. PubMed ID: 33020500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.
    Abu Bakar MH; Sarmidi MR
    Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Based on urine metabolomics to study the mechanism of Qi-deficiency affecting type 2 diabetes rats using ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
    Gao Y; Wu Y; Liu Z; Fu J; Zhang Y; Wu J; Liu S; Song F; Liu Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122850. PubMed ID: 34364297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of pathognomonic purine synthesis biomarkers by metabolomic profiling of adolescents with obesity and type 2 diabetes.
    Concepcion J; Chen K; Saito R; Gangoiti J; Mendez E; Nikita ME; Barshop BA; Natarajan L; Sharma K; Kim JJ
    PLoS One; 2020; 15(6):e0234970. PubMed ID: 32589682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
    Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
    Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
    Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
    PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Untargeted metabolomic profiling reveals molecular signatures associated with type 2 diabetes in Nigerians.
    Doumatey AP; Shriner D; Zhou J; Lei L; Chen G; Oluwasola-Taiwo O; Nkem S; Ogundeji A; Adebamowo SN; Bentley AR; Gouveia MH; Meeks KAC; Adebamowo CA; Adeyemo AA; Rotimi CN
    Genome Med; 2024 Mar; 16(1):38. PubMed ID: 38444015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometric based approaches in urine metabolomics and biomarker discovery.
    Khamis MM; Adamko DJ; El-Aneed A
    Mass Spectrom Rev; 2017 Mar; 36(2):115-134. PubMed ID: 25881008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific Metabolic Profiles and Their Relationship to Insulin Resistance in Recent-Onset Type 1 and Type 2 Diabetes.
    Knebel B; Strassburger K; Szendroedi J; Kotzka J; Scheer M; Nowotny B; Müssig K; Lehr S; Pacini G; Finner H; Klüppelholz B; Giani G; Al-Hasani H; Roden M;
    J Clin Endocrinol Metab; 2016 May; 101(5):2130-40. PubMed ID: 26829444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
    Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
    Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics of Type 1 and Type 2 Diabetes.
    Arneth B; Arneth R; Shams M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db mice.
    Mora-Ortiz M; Nuñez Ramos P; Oregioni A; Claus SP
    Metabolomics; 2019 Jun; 15(6):89. PubMed ID: 31179513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabonomic study of biochemical changes in urinary of type 2 diabetes mellitus patients after the treatment of sulfonylurea antidiabetic drugs based on ultra-performance liquid chromatography/mass spectrometry.
    Huo T; Xiong Z; Lu X; Cai S
    Biomed Chromatogr; 2015 Jan; 29(1):115-22. PubMed ID: 24890121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untargeted mass spectrometric approach in metabolic healthy offspring of patients with type 2 diabetes reveals medium-chain acylcarnitine as potential biomarker for lipid induced glucose intolerance (LGIT).
    Knebel B; Mack S; Lehr S; Barsch A; Schiller M; Haas J; Lange S; Fuchser J; Zurek G; Müller-Wieland D; Kotzka J
    Arch Physiol Biochem; 2016 Dec; 122(5):266-280. PubMed ID: 27373781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined untargeted and targeted metabolomic profiling reveals urinary biomarkers for discriminating obese from normal-weight adolescents.
    Cho K; Moon JS; Kang JH; Jang HB; Lee HJ; Park SI; Yu KS; Cho JY
    Pediatr Obes; 2017 Apr; 12(2):93-101. PubMed ID: 26910390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overlap in serum metabolic profiles between non-related diseases: Implications for LC-MS metabolomics biomarker discovery.
    Lindahl A; Forshed J; Nordström A
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1472-7. PubMed ID: 27581198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycerophospholipid Metabolism Alterations in Patients with Type 2 Diabetes Mellitus and Tuberculosis Comorbidity.
    López-Hernández Y; Lara-Ramírez EE; Salgado-Bustamante M; López JA; Oropeza-Valdez JJ; Jaime-Sánchez E; Castañeda-Delgado JE; Magaña-Aquino M; Murgu M; Enciso-Moreno JA
    Arch Med Res; 2019 Feb; 50(2):71-78. PubMed ID: 31349956
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.